C
57
4
HP
50
-2
CTSH
55
3
IFF
63
3
TEL
71
3
DE
30
2
MMC
57
3
FCX
56
2
TMO
50
-2
DNB
44
6
PBI
46
3
BBY
45
-3
BAC
62
5
CMS
50
2
BRK.B
40
2
NWSA
84
17
GPC
37
-3
KHC
27
-4
ZION
60
3
COST
60
4
C
57
4
HP
50
-2
CTSH
55
3
IFF
63
3
TEL
71
3
DE
30
2
MMC
57
3
FCX
56
2
TMO
50
-2
DNB
44
6
PBI
46
3
BBY
45
-3
BAC
62
5
CMS
50
2
BRK.B
40
2
NWSA
84
17
GPC
37
-3
KHC
27
-4
ZION
60
3
COST
60
4
Financhill
Back

Akoustis Technologies Vs. PTC Therapeutics Industry Stock Comparison

Sell
16

AKTS
Akoustis Technologies

Last Price:
0.12
Seasonality Move:
-9.97%
Sell
34

PTCT
PTC Therapeutics

Last Price:
30.41
Seasonality Move:
8.11%
Sell
16
Akoustis Technologies (AKTS) is a Sell

Is Akoustis Technologies a Buy, Sell or Hold?

  • The current Akoustis Technologies [AKTS] share price is $0.12. The Score for AKTS is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • AKTS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
34
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy, Sell or Hold?

  • The current PTC Therapeutics [PTCT] share price is $30.39. The Score for PTCT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKTS Stock Price Chart

What is Akoustis Technologies's stock price today?

  • The Akoustis Technologies share price today is $0.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTS is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTCT Stock Price Chart

What is PTC Therapeutics's stock price today?

  • The PTC Therapeutics share price today is $30.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight selling pressure.

AKTS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 31.66 Sell
Chaikin Money Flow: -3299288 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.13 - 0.19) Sell
Bollinger Bands (100): (0.25 - 0.67) Sell

PTCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.8 Sell
Relative Strength Index (14 RSI): 35.32 Sell
Chaikin Money Flow: -285238 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.46 - 37.72) Sell
Bollinger Bands (100): (26.79 - 35.21) Sell

AKTS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.13 Sell
20-day SMA: 0.14 Sell
50-day SMA: 0.31 Sell
200-day SMA: 0.57 Sell
8-day EMA: 0.13 Sell
20-day EMA: 0.16 Sell
50-day EMA: 0.27 Sell
200-day EMA: 0.8 Sell

PTCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.66 Sell
20-day SMA: 35.43 Sell
50-day SMA: 34.01 Sell
200-day SMA: 27.58 Buy
8-day EMA: 32.88 Sell
20-day EMA: 34.35 Sell
50-day EMA: 33.7 Sell
200-day EMA: 31.8 Sell

Akoustis Technologies Earnings Growth & AKTS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.35 per share.

PTC Therapeutics Earnings Growth & PTCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.

Akoustis Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

PTC Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):